| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1013915644 |
| P356 | DOI | 10.2165/00003495-199000401-00005 |
| P698 | PubMed publication ID | 2289406 |
| P2093 | author name string | G Assmann | |
| H Schulte | |||
| P2860 | cites work | Plasma fibrinogen--a major coronary risk factor | Q41879314 |
| Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 | ||
| Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study | Q67922812 | ||
| The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society | Q68466052 | ||
| Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society | Q69749258 | ||
| Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study | Q69886150 | ||
| Coagulation factors and the progress of coronary heart disease | Q69904817 | ||
| Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 | ||
| P304 | page(s) | 13-18 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Modelling the Helsinki Heart Study by means of risk equations obtained from the PROCAM Study and the Framingham Heart Study | |
| P478 | volume | 40 Suppl 1 |
| Q37719160 | Effects of simvastatin 20 mg/d on serum lipid profiles in Japanese hyperlipidemic patients: A prospective, open-label pilot study |
| Q35035100 | Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia |
| Q41018882 | The practical impact of pharmacoeconomics on institutional managers |
Search more.